World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
53
Citations
9044
World Ranking
2394
National Ranking
36

Santiago Montes-Moreno publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Santiago Montes-Moreno sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 167 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Santiago Montes-Moreno D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Santiago Montes-Moreno sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 53 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Santiago Montes-Moreno is affiliated with the Instituto de Investigación Marqués de Valdecilla in Spain. Their research primarily focuses on medicine, with significant contributions in pathology and forensic medicine, genetics, oncology, immunology, and rheumatology.

The main topics addressed in their work include:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • CAR-T cell therapy research
  • CNS Lymphoma Diagnosis and Treatment
  • IgG4-Related and Inflammatory Diseases
  • Chromatin Remodeling and Cancer

Montes-Moreno has published extensively in several key scientific venues, with frequent publications appearing in:

  • UNC Libraries
  • Blood
  • Revista Española de Patología
  • Hematological Oncology
  • Leukemia

Their notable recent papers include:

  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms," 2022, Leukemia
  • "Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma," 2020, Haematologica
  • "Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748," 2023, Leukemia
  • "Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up," 2020, Blood Cancer Journal
  • "ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer," 2021, Oncogene

Frequent co-authors of Montes-Moreno include:

  • Zijun Y. Xu-Monette
  • Govind Bhagat
  • Miguel Á. Piris
  • Alexandar Tzankov
  • Ken H. Young

Best Publications

  • EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

    A. W. Langerak;P. J. T. A. Groenen;M. Brüggemann;K. Beldjord

  • Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.

    J Menezes;F Acquadro;M Wiseman;G Gómez-López

  • The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.

    E Sánchez-Tilló;L Fanlo;L Siles;S Montes-Moreno

  • Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

    Qing Ye;Zijun Y Xu-Monette;Alexandar Tzankov;Lijuan Deng

  • miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

    Santiago Montes-Moreno;Nerea Martinez;Beatriz Sanchez-Espiridión;Ramon Díaz Uriarte

  • The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

    Lorena Di Lisio;Nerea Martinez;Santiago Montes-Moreno;Miguel Piris-Villaespesa

  • Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features

    George Kanellis;Manuela Mollejo;Santiago Montes-Moreno;Socorro-María Rodriguez-Pinilla

  • Identification of MNDA as a new marker for nodal marginal zone lymphoma

    G Kanellis;G Roncador;A Arribas;M Mollejo

  • Molecular Characterization of Immunoglobulin Gene Rearrangements in Diffuse Large B-Cell Lymphoma: Antigen-Driven Origin and IGHV4-34 as a Particular Subgroup of the Non-GCB Subtype

    Elena Sebastián;Miguel Alcoceba;Ana Balanzategui;Luis Marín

  • NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.

    Lina Odqvist;Margarita Sánchez-Beato;Santiago Montes-Moreno;Esperanza Martín-Sánchez

  • Plasmablastic Lymphoma Phenotype Is Determined by Genetic Alterations in MYC and PRDM1

    Santiago Montes-Moreno;Nerea Martinez-Magunacelaya;Tomás Zecchini-Barrese;Sonia Gonzalez de Villambrosía

  • Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases

    Santiago Montes-Moreno;Yolanda Castro;Socorro M Rodríguez-Pinilla;Juan F García

  • Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway

    María J. Bueno;Marta Gómez de Cedrón;Gonzalo Gómez-López;Ignacio Pérez de Castro

  • Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma

    J Schmidt;I Salaverria;A Haake;I Bonzheim

  • B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.

    José P. Vaqué;Nerea Martínez;Ana Batlle-López;Cristina Pérez

  • A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma

    Elena Beltran;Vicente Fresquet;Javier Martinez-Useros;Jose A. Richter-Larrea

  • SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms

    Santiago Montes-Moreno;Rocio Ramos-Medina;Azahara Martínez-López;Carlos Barrionuevo Cornejo

  • Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma.

    Zijun Y. Xu-Monette;Qipan Deng;Ganiraju C. Manyam;Alexander Tzankov

  • AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.

    Jinfen Wang;Zijun Y. Xu-Monette;Kausar J. Jabbar;Qi Shen

  • Erratum: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the international DLBCL rituximab-CHOP consortium program study (Leukemia (2014) 28 (980) Doi:10.1038/leu.2014.24)

    C. Visco;Y. Li;Z. Y. Xu-Monette;R. N. Miranda

Frequent Co-Authors

Miguel A. Piris
Miguel A. Piris Instituto de Salud Carlos III
Maurilio Ponzoni
Maurilio Ponzoni Vita-Salute San Raffaele University
Andrés J.M. Ferreri
Andrés J.M. Ferreri Vita-Salute San Raffaele University
Govind Bhagat
Govind Bhagat Columbia University
Eric D. Hsi
Eric D. Hsi Cleveland Clinic
Youli Zu
Youli Zu Houston Methodist
L. Jeffrey Medeiros
L. Jeffrey Medeiros The University of Texas MD Anderson Cancer Center
Margarita Sánchez-Beato
Margarita Sánchez-Beato Instituto de Salud Carlos III
Yong Li
Yong Li Baylor College of Medicine
Francesco Bertoni
Francesco Bertoni Institute of Oncology Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology often overlaps with other fields and career paths. Many students consider additional or alternative online degrees to broaden job prospects or specialize further. Fields such as bachelor in mathematics online can provide strong analytical and problem-solving skills highly valued in biological research.

Creative students might blend scientific expertise with visual communication through programs like a graphic design online degree. This combination is ideal for careers in scientific illustration or educational content development.

Flexibility is also key when planning your education. An online interdisciplinary studies degree financial aid can allow you to combine biology with other areas such as business, communication, or data science, often with guidance on available financial support.

For those seeking advanced credentials with a focus on affordability and speed, pursuing the quickest cheapest masters degree options could be a strategic choice, even in adjacent fields where biological perspectives add value. Consider all pathways to build a tailored and marketable skill set.

Best Scientists Citing Santiago Montes-Moreno

Trending Scientists

Recently Published Articles